Life Sciences: What's new in France?
November 30, 2022
Read more about the recent developments in the life sciences sector in France.
Content :
- Antitrust: European Commission prohibits acquisition of Grail by Illumina
- Regulatory: The French Administrative Supreme Court strengthens its control on decisions affecting drug pricing and reimbursement
- Regulatory: The commercial courts maintain jurisdiction on unfair competition claims for health products advertising, despite the French health agency’s vetting process
- Regulatory: Hybrid medicinal products: myth or reality?
Related Professionals
